Figure_6.tif (278.8 kB)
Download fileThe effects of recombinant human STIP1 (rhSTIP1) on ovarian cancer cells are neutralized by the co-treatment with anti-STIP1 antibodies.
figure
posted on 2013-02-28, 11:43 authored by Angel Chao, Chyong-Huey Lai, Chia-Lung Tsai, Swei Hsueh, Chuen Hsueh, Chiao-Yun Lin, Hung-Hsueh Chou, Yu-Jr Lin, Hsi-Wen Chen, Ting-Chang Chang, Tzu-Hao WangWhen anti-STIP1 antibodies (800 nM) were added to cancer cells previously exposed to 400 nM of rhSTIP1, cell proliferation (A) and migration (B) were inhibited. Data are presented as means ± standard errors of the means of three independent experiments.
